EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utilizing AI for decision support in severe asthma biological treatment

Bassam Mahboub, Sameer Alawnah, Salam Dhou, Piotr Kuna, Celine Bergeron, Riyad Al-Lehebi, Najla Alnahadi, Noura Alhousani, Assim Sagahyroon, Asharaf Alzabi, Laila Salameh

Frontiers in Digital Health · 30.10.2026 · 8

DOI: 10.3389/fdgth.2026.1939100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Digital Health, online erschienen am 30.10.2026. Verfasst von Bassam Mahboub und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Medicine, Dubai Health, Dubai, United Arab Emirates. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe asthma remains a major clinical challenge because of disease heterogeneity and variable response to biologic therapies. Despite the availability of clinical guidelines, clinicians often rely on a trial-and-error approach when selecting biologic treatments. We aimed to develop and validate an artificial intelligence (AI)-driven decision support system (DSS) to predict treatment response and support personalized biologic selection in severe asthma.

Methods

A retrospective multinational cohort of 801 patients with severe asthma from the United Arab Emirates, Saudi Arabia, Poland, and Canada was analyzed. Random Forest (RF) models were developed to predict clinical improvement, and Recursive Feature Elimination was used to identify the most informative predictors. Counterfactual simulation was subsequently applied to evaluate alternative biologic treatment strategies.

Results

The most important predictors of treatment response were Asthma Control Test (ACT) score, eosinophil count, and type 2 inflammatory comorbidities, particularly nasal polyposis and sinusitis. The optimized RF model improved specificity from 33.33% to 66.67% and increased overall accuracy from 78.57% to 82.14%. Counterfactual simulations demonstrated the model's ability to identify non-responder phenotypes and estimate alternative biologic options with higher predicted probabilities of improvement, including a 62% probability of improvement following a switch from anti-IgE therapy to anti-IL-5R therapy in selected patients.

Conclusion

This study demonstrates the potential of AI-driven clinical decision support to support personalized biologic selection in severe asthma. By improving identification of likely non-responders and simulating alternative treatment pathways, the proposed framework may help reduce ineffective treatment exposure, improve clinical decision-making, and advance precision medicine in severe asthma management.

Schlagwörter

Stichwörter der Autor:innen

arteficial intelligenceasthmabiological theraphyprecision medicinesevere asthma

Autor:innen und Institutionen

  • Pulmonary Medicine, Dubai Health, Dubai, United Arab Emirates.
  • Department of Computer Science and Engineering, American University of Sharjah, Sharjah, United Arab Emirates.
  • Division of Internal Medicine Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
  • Department of Medicine, Centre for Lung Health, Vancouver General Hospital, Vancouver, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Department of Pulmonology, King Fahad Medical City, Riyadh, Saudi Arabia.

Zitieren

APA

Mahboub, B., Alawnah, S., Dhou, S., Kuna, P., Bergeron, C., Al-Lehebi, R., Alnahadi, N., Alhousani, N., Sagahyroon, A., Alzabi, A., & Salameh, L. (2026). Utilizing AI for decision support in severe asthma biological treatment. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1939100

Vancouver

Mahboub B, Alawnah S, Dhou S, Kuna P, Bergeron C, Al-Lehebi R, et al. Utilizing AI for decision support in severe asthma biological treatment. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1939100

BibTeX
@article{Mahboub2026,
  author = {Mahboub, Bassam and Alawnah, Sameer and Dhou, Salam and Kuna, Piotr and Bergeron, Celine and Al-Lehebi, Riyad and Alnahadi, Najla and Alhousani, Noura and Sagahyroon, Assim and Alzabi, Asharaf and Salameh, Laila},
  title = {Utilizing AI for decision support in severe asthma biological treatment},
  journal = {Frontiers in Digital Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/fdgth.2026.1939100}
}
Kostenlos starten →